Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain.

It is shown that neither the set of directly determined blood-brain concentration ratios (BB) of Young and Mitchell nor the set of indirectly obtained values of Abraham and Weathersby are suitable for the construction of a general equation for the interpretation and prediction of log BB values. However, combination of both sets leads to the general equation log BB = -0.038 + 0.198R2 - 0.687 pi H2 - 0.715 alpha H2 - 0.698 beta H2 + 0.995Vx (n = 57, rho = 0.9522, sd = 0.197, F = 99.2), where the solute descriptors are R2, an excess molar refraction; pi H2, the dipolarity/polarizability, alpha H2 and beta H2, the effective or summation hydrogen-bond acidity and basicity; and Vx, the characteristic volume of McGowan. Thus solute dipolarity/polarizability, hydrogen-bond acidity, and hydrogen-bond basicity favor blood, and solute size, as Vx, favors brain. Methods are given for the estimation of solute descriptors through fragment schemes, so that log BB values themselves may be obtained simply from knowledge of solute molecular structure.

[1]  H. Haggard.  THE ABSORPTION, DISTRIBUTION, AND ELIMINATION OF ETHYL ETHER III. THE RELATION OF THE CONCENTRATION OF ETHER, OR ANY SIMILAR VOLATILE SUBSTANCE, IN THE CENTRAL NERVOUS SYSTEM TO THE CONCENTRATION IN THE ARTERIAL BLOOD, AND THE BUFFER ACTION OF THE BODY , 1924 .

[2]  P. Böhlen,et al.  Uptake and distribution of hexane in rat tissues. , 1973, Toxicology and applied pharmacology.

[3]  R. Taft,et al.  Solubility properties in polymers and biological media. 2. The correlation and prediction of the solubilities of nonelectrolytes in biological tissues and fluids. , 1985, Journal of medicinal chemistry.

[4]  R Griffiths,et al.  Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1‐receptor antagonist with negligible ability to penetrate the central nervous system , 1986, British journal of pharmacology.

[5]  M. Abraham,et al.  The use of characteristic volumes to measure cavity terms in reversed phase liquid chromatography , 1987 .

[6]  R Griffiths,et al.  Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.

[7]  N el Tayar,et al.  Partitioning of solutes in different solvent systems: the contribution of hydrogen-bonding capacity and polarity. , 1991, Journal of pharmaceutical sciences.

[8]  Michael H. Abraham,et al.  Hydrogen bonding: XVII. The characterisation of 24 gas-liquid chromatographic stationary phases studied by Poole and co-workers. including molten salts, and evaluation of solute-stationary phase interactions , 1991 .

[9]  M. Abraham,et al.  Hydrogen bonding: XXI. Solvation parameters for alkylaromatic hydrocarbons from gas-liquid chromatographic data , 1992 .

[10]  M. Kansy,et al.  Hydrogen-Bonding Capacity and Brain Penetration , 1992, Chimia (Basel).

[11]  The History of Drug Research: From Overton to Hansch , 1992 .

[12]  Bernard Testa,et al.  Polar intermolecular interactions encoded in partition coefficients: an indirect estimation of hydrogen-bond parameters of polyfunctional solutes , 1992 .

[13]  Michael H. Abraham,et al.  Hydrogen bonding. 31. Construction of a scale of solute effective or summation hydrogen‐bond basicity , 1993 .

[14]  Michael H. Abraham,et al.  Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes , 2010 .